Story · Medicine & Biotech

Aakash Desai: Can Computational Pathology Improve TROP2 Biomarker Selection in NSCLC?

1 outlet · first reported by OncoDaily on

Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on LinkedIn: “A digital TROP2 score separated who benefited from Dato-DXd in nonsquamous NSCLC, in a new Nature Portfolio Nature (OncoDaily)

Coverage, in order

  1. OncoDaily obscure
    Aakash Desai: Can Computational Pathology Improve TROP2 Biomarker Selection in NSCLC?

    Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on LinkedIn: “A digital TROP2 score separated who benefited from Dato-DXd in nonsquamous NSCLC, in a new Nature Portfolio Nature

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.